NICE recommends olaparib for the treatment of ovarian and prostate cancer
The National Institute for Health and Care Excellence has recommended the NHS funds olaparib for the maintenance treatment of advanced ovarian cancer in women with BRCA1 and 2 variants and advanced or metastatic prostate cancer in men...